Document is current
Any future updates will be listed below
-
Authors
Blake, Erin A. https://orcid.org/0000-0002-5097-4837
Ross, Malcolm S.
Ross, Megan E.
Matsuo, Koji
Silverstein, Emily T.
Torno, Lilibeth R.
Bhargava, Rohit
Post, Miriam D.
Da Silva, Diane M.
Taylor, Sarah
Walia, Saloni
Roman, Lynda
McEachron, Troy A.
-
Funding
Funding for this research was provided by:
USC Department of Gynecologic Oncology Research Fund
- License Information
-
More Information
Article History
Received: 8 May 2020
Accepted: 27 July 2021
First Online: 15 August 2021
Declarations
:
: Erin Blake: none; Troy McEachron: none; Malcolm Ross: none; Megan Ross: none; Rohit Bhargava: none; Miriam Post: none; Saloni Walia: none; Koji Matsuo: Chugai (honorarium 2016), Springer (textbook editorial expense 2018), VBL Therapeutics (investigator meeting attendance expense 2019); Diane da Silva: Venn Biosciences (grant researching ovarian cancer biomarkers), Quantum screening (consulting fees); Lynda Roman: Tempus Lab (consultant > 2 years ago, none relevant to submission), Quantgene (consultant, not relevant to submission); Lilibeth Torno: none; Emily Silverstein: none.
: USC Health Sciences Institutional Review Board approved (HS-18-00266). Approval letter available upon request.
: Informed consent was not necessary for this study.
